Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 1999 10:08 ET | Source: RiboGene, Inc.

RiboGene, Inc. Shares Recommended by WallStreet Research

HAYWARD, Calif., Sept. 29, 1999 (PRIMEZONE) - RiboGene, Inc. (AMEX:RBO) shares have recently been recommended in an analyst report just released by WallStreet Research, a prominent research boutique...
August 05, 1999 16:30 ET | Source: Donner Corp. International

Donner Corp. International Reiterates Strong Buy Recommendation on Cypros Pharmaceutical Based on News of Merger with Ribogene

SANTA ANA, Calif., Aug. 5, 1999 (PRIMEZONE) -- The following is being issued by Donner Corporation International, a member of the National Association of Securities Dealers, CRD number...
May 28, 1999 09:06 ET | Source: RiboGene, Inc.

Ribogene to Appear at the Wall Street Forum Boston Conference June 3

HAYWARD, Calif., May 28, 1999 (PRIMEZONE) -- RiboGene Inc. (AMEX: RBO), a biotechnology company focused on the discovery and development of novel therapeutics for the treatment of infectious diseases...
December 02, 1998 09:00 ET | Source: Alan Stone and Company

RiboGene, Inc. Shares Recommended by WallStreet Research

HAYWARD, Calif. - Dec. 2, 1998 (PRIMEZONE) - RiboGene, Inc. (AMEX:RBO), announced that the Company's shares have recently been recommended in an analyst report released by WallStreet Research, a...